Charles River Laboratories International Inc (CRL)

226.08 +1.40  +0.62% NYSE Nov 25, 17:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/11/2021 Earnings Charles River Laboratories International Inc Fourth Quarter Earnings for 2020 Release
02/11/2021 08:30 EST Misc Charles River Laboratories International Inc Fourth Quarter Earnings Conference Call for 2020
10/29/2020 Earnings Charles River Laboratories International Inc Third Quarter Earnings Result for 2020
10/29/2020 09:30 EDT Misc Charles River Laboratories International Inc Third Quarter Earnings Conference Call for 2020
08/05/2020 09:30 EDT Misc Charles River Laboratories International Inc Second Quarter Earnings Conference Call for 2020
08/05/2020 Earnings Charles River Laboratories International Inc Second Quarter Earnings Result for 2020
05/07/2020 Earnings Charles River Laboratories International Inc First Quarter Earnings Result for 2020
05/07/2020 09:30 EDT Misc Charles River Laboratories International Inc First Quarter Earnings Conference Call for 2020
05/06/2020 Misc Charles River Laboratories International Inc Annual General Meeting for 2019
02/11/2020 08:30 EST Misc Charles River Laboratories International Inc Fourth Quarter Earnings Conference Call for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.criver.com
  • Investor Relations URL: http://ir.criver.com/phoenix.zhtml?c=121668&p=irol-presentations
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Feb. 11, 2021
  • Last Earnings Release: Oct. 29, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Charles River Laboratories is a leading provider of drug discovery and development services. With roughly 50% of market share worldwide, the research model and services segment is the leading provider of animal models for laboratory testing. About half of the company's revenue comes from drug discovery and preclinical testing, and one fourth comes from the manufacturing support segment.

Top Fund Holders

Symbol Name Weighting
FID1716 Fidelity Small Cap America Cl S5 6.19%
FID4995 Fidelity Small Cap America Series P1T5 6.19%
FBT First Trust NYSE Arca Biotech ETF 3.26%
BMRRX BlackRock Mid-Cap Growth Equity R 1.96%
FXH First Trust Health Care AlphaDEX® ETF 1.92%
EBCGX MFS Mid Cap Growth 529B 1.66%
IJK iShares S&P Mid-Cap 400 Growth ETF 1.08%
MDY SPDR® S&P MIDCAP 400 ETF Trust 0.67%
IJH iShares Core S&P Mid-Cap ETF 0.60%
NAESX Vanguard Small Cap Index Inv 0.29%
VB Vanguard Small-Cap ETF 0.29%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.